Brandon Scott Mogrovejo, MD

Zvi S. Marans, MD, associate professor of Pediatrics at Columbia University Medical Center, is a full time faculty member of the Division of Pediatric Cardiology at Columbia. He is based in northern New Jersey, and is the founding and managing partner of a large, regional pediatric cardiology practice in Paramus, NJ. His practice, established in 1990, provides the highest quality academic specialty care in the context of a compassionate and nurturing environment. He specializes in congenital and acquired heart disease in children, and has a specialty interest in fetal cardiology. Dr. Marans is a skilled educator, and teaches a regular class in cardiac anatomy to the Columbia pediatric cardiology fellows. In addition, he is an attending at the pediatric cardiac neonatal intensive care unit at Morgan Stanley Children’s Hospital at Columbia. His partners are also graduates of the Columbia training program and are full time faculty members at Columbia. He is married to Nina Kampler, a lawyer and retail real estate strategist, and is the father of four children.

Dr. Ramsay Fuleihan is the clinical director of the Division of Pediatric Allergy, Immunology and Rheumatology and a professor of pediatrics at Columbia. Throughout his career his main research interest has been the pathogenesis and treatment of primary immunodeficiency diseases. Dr. Fuleihan was formerly chief of the division of allergy and immunology at Sidra Medical and Research Center in Qatar, and Director of Primary Immunodeficiency Clinical Services and the Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies at Ann & Robert H Lurie Children’s Hospital of Chicago. Dr. Fuleihan earned his medical degree from the American University of Beirut in Lebanon, completed his pediatric residency at Duke University Medical Center, and fellowship in allergy and immunology at the Children’s Hospital-Boston at Harvard Medical School. Dr. Fuleihan is a member of the Board of Directors of the American Board of Allergy and Immunology. He is an active fellow of the American Academy of Allergy Asthma and Immunology, where he served as Chair of the Primary Immunodeficiency Committee; a member of the Clinical Immunology Society, where he served as chair of the CME committee; a member of the European Society for Immunodeficiencies; and a member of the Society for Pediatric Research. He serves on the Medical Advisory Committee of the Immune Deficiency Foundation and on the Board of Directors of Bounce Children’s Foundation.

I am a pediatric endocrinologist with interests that include polycysytic ovary syndrome (PCOS), bone health, disorders of puberty, thyroid disorders, pituitary disorders and growth disorders. In addition to my training in pediatrics and pediatric endocrinology, I have Master of Science degrees in Nutrition (1999) and in Patient Oriented Research (2014) and have completed a research fellowship at the Body Composition Unit of Columbia University Medical Center (2003). I comleted the TRANSFORM KL2 program sponsored by the Irving Institute of Clinical and Translational Research, a mentored career development program. My responsibilites include my clinical practice, overseeing clinical and research fellows, mentoring students, and running a clinical study. I have been certified as a clinical densitometrist by the International Society of Clinical Densitometry and interpret pediatric bone mineral density studies performed at Columbia University Irving Medical Center. My research project, “A double-blind placebo-controlled randomized clinical trial assessing the efficacy of metformin for hepatic fat in adolescents and young adults with polycystic ovary syndrome” has the primary goal of exploring the use of novel and noninvasive testing and a pilot double-blind placebo-controlled trial of metformin with the intention of identifying and potentially treating non-alcoholic fatty liver disease in adolescents and young adults with PCOS. My research is unique in that it uses minimally invasive body composition methodology, which makes it particularly attractive for use in adolescents and young adults. My overall clinical research goal is early identification and treatment of metabolic and body composition abnormalities associated with PCOS and to prevent lifelong morbidity associated with this disorder in a young population